Clinical Trial Update: The SAPPHIRE Study (Systolic And Pulse Pressure Hemodynamic Improvement By Restoring Elasticity) [Phase 2]

View source ↗

Summary

The SAPPHIRE Phase 2 trial evaluating systolic and pulse pressure hemodynamic restoration for hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Snippet

Sponsor: Synvista Therapeutics, Inc | Conditions: Hypertension | Phase 2 | Status: COMPLETED